Point72 Asset Management »

Ani Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.5M 7.5M 1.26

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
BlackRock
Context Capital Management
Jpmorgan Chase & Co
Leucadia National Corporation
Point72 Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals